Ligand Pharmaceuticals | LGND - Ativo Circulante





Ativo Circulante Alterar Data
Agenus USD 78.81M 16.47M 2026-06
Amgen USD 34.96B 3.49B 2026-06
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
Baxter International USD 6.99B 142M 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Enviri Corporation USD 722.11M 1.43M 2026-03
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Glaxosmithkline GBP 17.76B 5.83B 2026-03
Heron Therapeutics USD 229.84M 861K 2026-06
Insmed USD 1.63B 20.75M 2026-06
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
MacroGenics USD 321.69M 139.16M 2026-06
Merck USD 36.68B 1.66B 2026-06
Pacira USD 615.21M 100.25M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Veracyte USD 574.78M 52.6M 2026-06